FIELD: medicine.
SUBSTANCE: invention concerns medicinal agents, particularly application as an agent for correction of female reproductive dysfunction caused by cytostatic exposure, namely a preparation thio-fan-bis-1[(3,5-di-tert-butyl-4-hydroxyphenyl)propyl]sulphide which is a sulphur phenolic antioxidant.
EFFECT: problem to be solved by said invention is extended range of the therapeutic agents used for correction of female reproductive dysfunction caused by cytostatic exposure with reduction of by-effects.
3 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
CORRECTOR FOR DISORDERS OF FEMALE REPRODUCTIVE FUNCTION CAUSED BY CYTOSTATIC PREPARATIONS | 2003 |
|
RU2253468C2 |
MEANS FOR CORRECTION OF PATHOLOGIC CHANGES OF VIABLE OFFSPRING, CAUSED BY CYTOSTATIC IMPACT ON MOTHER'S ORGANISM | 2014 |
|
RU2552612C1 |
METHOD OF CORRECTING, CAUSED BY CYTOSTATIC IMPACT | 2009 |
|
RU2406527C1 |
AGENT FOR IMPROVING REPRODUCTIVE FUNCTION | 2012 |
|
RU2487705C1 |
AGENT FOR STIMULATING REPRODUCTIVE FUNCTION | 2014 |
|
RU2564016C1 |
AGENT FOR TREATING FEMALE INFERTILITY AND INFERTILITY OF FEMALE ANIMALS | 2017 |
|
RU2740922C2 |
METHOD OF IMPROVING AND/OR RECOVERY OF REPRODUCTIVE FUNCTION | 2009 |
|
RU2414215C1 |
AGENT FOR IMPROVING REPRODUCTIVE FUNCTION | 2012 |
|
RU2489142C1 |
MEANS FOR CORRECTION OF OVARY DAMAGE CAUSED BY CYTOSTATIC EFFECT | 2021 |
|
RU2785397C1 |
MEANS FOR PREVENTING AND CORRECTING SPERMATOGENESIS DISORDERS CAUSED BY CYTOSTATIC TREATMENT | 2006 |
|
RU2318529C1 |
Authors
Dates
2009-09-20—Published
2008-02-04—Filed